Author

Sarem Sarem

Observed name: Sarem, Sarem

Institution: Health Canada

Observed institutions: Health Canada, Centre Hospitalier Universitaire Sainte-Justine, CHU Sainte-Justine Research Center, Centre de recherches mathématiques, McGill University, Université de Montréal

OpenAlex ID: A5000818410

Model‐Informed Drug Development: Steps Toward Harmonized Guidance

2023 · Scott Marshall, Malidi Ahamadi, et al. · Clinical Pharmacology & Therapeutics · 36

Bayesian approach for the estimation of cyclosporine area under the curve using limited sampling strategies in pediatric hematopoietic stem cell transplantation

2014 · Sarem Sarem, Jun Li, et al. · Theoretical Biology and Medical Modelling · 9

Impact of sampling time deviations on the prediction of the area under the curve using regression limited sampling strategies

2015 · Sarem Sarem, Fahima Nekka, et al. · Biopharmaceutics & Drug Disposition · 7

Limited Sampling Strategies for Estimating Intravenous and Oral Cyclosporine Area Under the Curve in Pediatric Hematopoietic Stem Cell Transplantation

2014 · Sarem Sarem, Fahima Nekka, et al. · Therapeutic Drug Monitoring · 5

Designing Dose-Optimization Studies in Cancer Drug Development: Discussions with Regulators

2023 · Olga Marchenko, Rajeshwari Sridhara, et al. · Statistics in Biopharmaceutical Research · 4

Compliance descriptors: Analysis and evaluation in terms of therapeutic effect

2010 · Sarem Sarem, Jun Li, et al. · Biopharmaceutics & Drug Disposition · 2

Limited sampling strategies for estimation of cyclosporine exposure in pediatric hematopoietic stem cell transplant recipients : methodological improvement and introduction of sampling time deviation analysis

2014 · Sarem, Sarem

Modélisation de l’observance et détermination de son impact biopharmaceutique

2009 · Sarem, Sarem

Works count: 9

Citation count: 63

H-index: 4

I10-index: 1